Shire plc (
Q4 2010 Earnings Call
February 10, 2011 9:00 am ET
Eric Rojas - Director, North America Investor Relations
Angus Russell - Chief Executive Officer
Graham Hetherington - Chief Financial Office
Mike Cola - President, Specialty Pharmaceuticals
Sylvie Grégoire - President, Human Genetic Therapies
Ken Cacciatore - Cowen and Company, LLC.
Peter Verdult - Morgan Stanley Dean Witter
David Buck - Buckingham Research Group
Kerry Holford - Credit Suisse
David Steinberg - Deutsche Bank Securities Inc.
Graham Parry - Merrill Lynch
Brian Bourdot - Barclays Capital
Frank Pinkerton - SunTrust Robinson Humphrey
A very good day to you, ladies and gentlemen. Welcome to the Shire 2010 Full-Year Results Conference Call hosted by Angus Russell. My name is Nancy, I'm the operator for the call today. Your lines will remain on listen-only throughout the conference. (Operator Instructions) I'd like to advice all parties this call is being recorded for replay purposes.
I would now like to hand the call over to Eric Rojas. Please go ahead.
Thanks, Nancy. Good morning and good afternoon, everyone. Thank you for joining us today for Shire's full-year 2010 financial results. By now you should have all received our press release and should be viewing our presentation via our website on shire.com. If for some reasons you have not received the press release or are unable to access our website, please contact Souheil Salah in our UK Investor Relations Department on +44-1256-894-160 and he will be happy to assist you.